CXCR4 and glioblastoma: In GBM, the signal transduction pathways and regulation of CXCR4 are essential for sustained invasion (Rubin et al. 2003), enhanced angiogenesis (Kioi et al. 2010), and the migration of glioma stem cells, leading to therapeutic resistance (Goffart et al. 2015).